99 related articles for article (PubMed ID: 149590)
1. Susceptibilities of normal and malignant human lung cells in culture to the cytocidal action of antitumor agents.
Tsukeda H; Mizuno S; Nitta K
Cancer Res; 1978 Aug; 38(8):2529-32. PubMed ID: 149590
[TBL] [Abstract][Full Text] [Related]
2. Multidrug sensitivity phenotype of human lung cancer cells associated with topoisomerase II expression.
Giaccone G; Gazdar AF; Beck H; Zunino F; Capranico G
Cancer Res; 1992 Apr; 52(7):1666-74. PubMed ID: 1312895
[TBL] [Abstract][Full Text] [Related]
3. Differential sensitivities of five rat hepatoma cell lines to anticancer drugs.
Barranco SC; Haenelt BR; Gee EL
Cancer Res; 1978 Mar; 38(3):656-60. PubMed ID: 75057
[TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.
Ohe Y; Nakagawa K; Fujiwara Y; Sasaki Y; Minato K; Bungo M; Niimi S; Horichi N; Fukuda M; Saijo N
Cancer Res; 1989 Aug; 49(15):4098-102. PubMed ID: 2472873
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of a C-raf antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted subcutaneously into nude mice.
Geiger T; Müller M; Monia BP; Fabbro D
Clin Cancer Res; 1997 Jul; 3(7):1179-85. PubMed ID: 9815797
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity of lonidamine alone and in combination with other drugs against murine RIF-1 and human HT1080 cells in vitro.
Ning SC; Hahn GM
Cancer Res; 1990 Dec; 50(24):7867-70. PubMed ID: 2253227
[TBL] [Abstract][Full Text] [Related]
7. Potentiation by squalene of the cytotoxicity of anticancer agents against cultured mammalian cells and murine tumor.
Nakagawa M; Yamaguchi T; Fukawa H; Ogata J; Komiyama S; Akiyama S; Kuwano M
Jpn J Cancer Res; 1985 Apr; 76(4):315-20. PubMed ID: 2408954
[TBL] [Abstract][Full Text] [Related]
8. Drug-induced DNA hypermethylation and drug resistance in human tumors.
Nyce J
Cancer Res; 1989 Nov; 49(21):5829-36. PubMed ID: 2790794
[TBL] [Abstract][Full Text] [Related]
9. Use of 5-fluorodeoxycytidine and tetrahydrouridine to exploit high levels of deoxycytidylate deaminase in tumors to achieve DNA- and target-directed therapies.
Mekras JA; Boothman DA; Perez LM; Greer S
Cancer Res; 1984 Jun; 44(6):2551-60. PubMed ID: 6539164
[TBL] [Abstract][Full Text] [Related]
10. [Current results and perspectives of the use of human tumor cell lines for antitumor drug screening].
Zhukova OS; Dobrynin IaV
Vopr Onkol; 2001; 47(6):706-9. PubMed ID: 11826493
[TBL] [Abstract][Full Text] [Related]
11. Differential killing efficacy of twenty antitumor drugs on proliferating and nonproliferating human tumor cells.
Drewinko B; Patchen M; Yang LY; Barlogie B
Cancer Res; 1981 Jun; 41(6):2328-33. PubMed ID: 7237431
[TBL] [Abstract][Full Text] [Related]
12. Effect of melatonin on cytotoxicity of doxorubicin toward selected cell lines (human keratinocytes, lung cancer cell line A-549, laryngeal cancer cell line Hep-2).
Fic M; Podhorska-Okolow M; Dziegiel P; Gebarowska E; Wysocka T; Drag-Zalesinska M; Zabel M
In Vivo; 2007; 21(3):513-8. PubMed ID: 17591362
[TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of the differential cytotoxicity of keto-C-glycosides toward normal and malignant cells.
Bennani-Baiti IM; Lafarge-Frayssinet C; Herscovici J; Monserret R; Robbana-Barnat S; Antonakis K; Frayssinet C; Uriel J
Anticancer Res; 1993; 13(2):467-73. PubMed ID: 8517664
[TBL] [Abstract][Full Text] [Related]
14. An adriamycin-resistant subline is more sensitive than the parent human small cell lung cancer cell line to lonidamine.
Kiura K; Ohnoshi T; Ueoka H; Takigawa N; Tabata M; Segawa Y; Shibayama T; Kimura I
Anticancer Drug Des; 1992 Dec; 7(6):463-70. PubMed ID: 1337430
[TBL] [Abstract][Full Text] [Related]
15. Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines.
Teicher BA; Cucchi CA; Lee JB; Flatow JL; Rosowsky A; Frei E
Cancer Res; 1986 Sep; 46(9):4379-83. PubMed ID: 3731096
[TBL] [Abstract][Full Text] [Related]
16. [Update of human tumor clonogenic assay in carcinoma of the lung].
Kanzawa F
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1552-9. PubMed ID: 2992395
[TBL] [Abstract][Full Text] [Related]
17. [Sensitivity of antineoplastic agents in squamous cell carcinoma of the uterine cervix xenografted into nude mice].
Kawabata M; Hosokawa H; Katoh K; Izumi R
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3058-63. PubMed ID: 2445295
[TBL] [Abstract][Full Text] [Related]
18. In vitro chemosensitivity of human lung cancer cell lines.
Ruckdeschel JC; Carney DN; Oie HK; Russell EK; Gazdar AF
Cancer Treat Rep; 1987; 71(7-8):697-704. PubMed ID: 3038314
[TBL] [Abstract][Full Text] [Related]
19. Nicotinamide adenine dinucleotide (phosphate): quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: quinone cytotoxicity and selectivity in human lung and breast cancer cell lines.
Beall HD; Murphy AM; Siegel D; Hargreaves RH; Butler J; Ross D
Mol Pharmacol; 1995 Sep; 48(3):499-504. PubMed ID: 7565631
[TBL] [Abstract][Full Text] [Related]
20. Dihydrofluorouracil, a fluorouracil catabolite with antitumor activity in murine and human cells.
Diasio RB; Schuetz JD; Wallace HJ; Sommadossi JP
Cancer Res; 1985 Oct; 45(10):4900-3. PubMed ID: 3928143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]